Table 2 Differences in cognitive function across the three groups (raw scores) (M ± SD).

From: Abnormal eye movement, brain regional homogeneity in schizophrenia and clinical high-risk individuals and their associated gene expression profiles

Domains of MCCB

FSZ

CHR

HC

F

p

FSZ vs CHR

FSZ vs HC

CHR vs HC

p

p

p

Speed of Processing

36.73 ± 7.12

42.29 ± 8.48

49.05 ± 8.55

13.890

0.000

0.023

0.000

0.004

Attention / Vigilance

49.41 ± 9.44

68.92 ± 26.80

53.04 ± 11.04

8.074

0.000

0.000

0.485

0.003

Working Memory

46.09 ± 10.66

47.29 ± 12.89

46.58 ± 6.24

0.081

0.922

0.691

0.870

0.805

Verbal Learning

36.17 ± 9.52

44.92 ± 12.79

45.81 ± 11.68

5.133

0.008

0.011

0.004

0.784

Visual Learning

43.39 ± 15.13

43.43 ± 11.97

53.54 ± 10.98

5.247

0.008

0.991

0.007

0.007

Reasoning and Problem Solving

45.73 ± 13.63

48.67 ± 14.00

53.27 ± 7.78

2.429

0.096

0.409

0.033

0.180

  1. FSZ first-episode schizophrenia, CHR clinical high-risk, HC healthy controls, MCCB Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery.
Back to article page